Measuring the Effect of Radiation Therapy on Patient Activity Levels

Terminated

• Conditions: Head and Neck Cancer; Prostate Cancer; Breast Cancer; Lung Cancer

• Registration Number: NCT02694380
• Lead Sponsor: University of Pittsburgh

Brief Summary

The goal of this study is to measure the effect of radiation therapy on the activity levels of patients. This will be achieved by tracking their activity levels during a treatment course of radiation therapy.

Detailed Description

At the University of Pittsburgh (UPMC) St. Margaret and UPMC Shadyside, in the department of radiation oncology, breast, prostate, head and neck, and lung cancer patients will receive the standard treatment for their cancer and in no way will this study interfere with this treatment. Prior to initiation of radiation, consenting patients will be given Misfit activity tracking devices (accelerometers) to be worn on their wrist to track their activity levels throughout the course radiation therapy. Bracelets will be given to patients by the PI or co-investigators (MDs involved in patient's care) at date of consent and returned at completion of the study. The bracelets will track daily steps taken, calories burned, miles walked, and restful and restless sleep. Again, the purpose of the study is merely to measure the affect radiation therapy has on activity levels of patients.

Study Timeline

• Study Start: 2015-07
• Study First Submitted: 2016-01-27
• Study First Submitted QC: 2016-02-23
• Study First Posted: 2016-02-29
• Primary Completion: 2018-07
• Study Completion: 2018-07
• Status Verified: 2018-08
• Last Update Submitted: 2018-08-07
• Last Update Posted: 2018-08-09

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

• Diagnosis of Breast, Prostate, Lung or Head and Neck Cancer
• Eastern Cooperative Oncology Group (ECOG) performance status of 0-1
• Ability to walk 100 feet without rest
• Signed informed consent

Read More

Exclusion Criteria

• Any other noncutaneous cancer diagnosis under active treatment
• Known metastatic disease

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Activity level	up to 15 weeks	Misfit activity tracking devices (accelerometers) will be worn by patients to track their activity levels 1 day to 4 weeks before radiotherapy, during radiotherapy, and for 1 day to 4 weeks after radiotherapy.

Trial Locations

Locations (2)

UPMC St. Margaret Department of Radiation Oncology; 🇺🇸 Pittsburgh, Pennsylvania, United States

UPMC Shadyside Department of Radiation Oncology; 🇺🇸 Pittsburgh, Pennsylvania, United States